IL84154A0 - Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same - Google Patents
Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the sameInfo
- Publication number
- IL84154A0 IL84154A0 IL84154A IL8415487A IL84154A0 IL 84154 A0 IL84154 A0 IL 84154A0 IL 84154 A IL84154 A IL 84154A IL 8415487 A IL8415487 A IL 8415487A IL 84154 A0 IL84154 A0 IL 84154A0
- Authority
- IL
- Israel
- Prior art keywords
- immunodeficiency virus
- insect cells
- human immunodeficiency
- same
- immune deficiency
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 title 1
- 241000238631 Hexapoda Species 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
- 241000701447 unidentified baculovirus Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6045—RNA rev transcr viruses
- C12N2810/6054—Retroviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92019786A | 1986-10-16 | 1986-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL84154A0 true IL84154A0 (en) | 1988-03-31 |
Family
ID=25443341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL84154A IL84154A0 (en) | 1986-10-16 | 1987-10-13 | Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0265785A3 (pl) |
| JP (1) | JPS63207397A (pl) |
| CN (1) | CN87107837A (pl) |
| AR (1) | AR241940A1 (pl) |
| AU (2) | AU7984287A (pl) |
| BR (1) | BR8705535A (pl) |
| DD (3) | DD283935A5 (pl) |
| DK (1) | DK541987A (pl) |
| FI (1) | FI874564A7 (pl) |
| HU (1) | HUT45095A (pl) |
| IE (1) | IE872748L (pl) |
| IL (1) | IL84154A0 (pl) |
| LT (3) | LTIP1792A (pl) |
| LV (1) | LV10654B (pl) |
| PL (2) | PL161448B1 (pl) |
| ZA (1) | ZA877752B (pl) |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63258575A (ja) * | 1986-12-15 | 1988-10-26 | レプリゲン コーポレーション | 昆虫細胞中でつくられる組換えｈｉｖエンベロープタンパク |
| IL85149A0 (en) * | 1987-01-27 | 1988-06-30 | Microgenesys Inc | Hiv gp160 aids virus envelope protein-containing substrates and methods for detection of aids antibody thereby |
| US5681713A (en) * | 1987-05-08 | 1997-10-28 | Smithkline Beecham Corporation | Expression of heterologous proteins in Drosophila cells |
| IL89118A0 (en) * | 1988-02-03 | 1989-08-15 | Microgenesys Inc | Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1 |
| IL90048A0 (en) * | 1988-04-25 | 1989-12-15 | Merck & Co Inc | Recombinant gag precursor of hiv,its preparation and its use as aids vaccine |
| JP2511494B2 (ja) * | 1988-05-12 | 1996-06-26 | 善治 松浦 | 日本脳炎ウイルス表面抗原蛋白質の製造法 |
| CA2003300A1 (en) * | 1988-11-21 | 1990-05-21 | Franklin Volvovitz | Skin test and test kit for aids |
| JP2852431B2 (ja) * | 1988-12-07 | 1999-02-03 | 財団法人阪大微生物病研究会 | レトロウイルスのプロテアーゼ、逆転写酵素及びエンドヌクレアーゼ、並びにこれ等の酵素の製法 |
| US5194376A (en) * | 1989-02-28 | 1993-03-16 | University Of Ottawa | Baculovirus expression system capable of producing foreign gene proteins at high levels |
| AU5184190A (en) * | 1989-02-23 | 1990-09-26 | University Of Ottawa | Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine |
| WO1990010078A1 (en) * | 1989-02-23 | 1990-09-07 | University Of Ottawa | Improved baculovirus expression system capable of producing foreign gene proteins at high levels |
| IL93599A0 (en) * | 1989-03-03 | 1990-12-23 | Microgenesys Inc | Kit and/or composition for the prevention or treatment of aids |
| EP0406857B1 (en) * | 1989-07-07 | 1995-05-24 | Takeda Chemical Industries, Ltd. | Proteins and production thereof |
| EP0421626A1 (en) * | 1989-09-19 | 1991-04-10 | Merck & Co. Inc. | Vaccine for aids and hepatitis B |
| US5346989A (en) * | 1990-08-22 | 1994-09-13 | Syntello Vaccine Development Kb | Peptides for use in induction of T cell activation against HIV-1 |
| DK0638174T3 (da) * | 1992-04-24 | 1997-10-20 | Us Gov Health & Human Serv | Detektion af mæslingevirusspecifikke antistoffer under anvendelse af rekombinante mæslingeproteiner |
| DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
| JP2002512501A (ja) | 1996-07-03 | 2002-04-23 | メリアル インコーポレイテッド | 外来性ｄｎａを含む組換えイヌアデノウィルス（ｃａｖ） |
| US6517843B1 (en) | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
| US6224882B1 (en) | 1997-11-07 | 2001-05-01 | Protein Science Corp. | Insect cells or fractions as adjuvant for antigens |
| JP2002030098A (ja) * | 2000-07-17 | 2002-01-29 | Institute Of Immunology Co Ltd | バキュロウィルスの発芽ウイルスからウイルスエンベロープを回収する方法 |
| JP2006516883A (ja) | 2002-09-19 | 2006-07-13 | アメリカ合衆国 | Ｐ．アリアシポリペプチド、ユウガイサシチョウバエポリペプチド、および使用法 |
| DE60327366D1 (de) | 2002-10-29 | 2009-06-04 | Fundacao Oswaldo Cruz | Lutzomyia longipalpis-polypeptide und verwendungsverfahren |
| EP2390352A1 (en) | 2003-03-18 | 2011-11-30 | Quantum Genetics Ireland Limited | Systems and methods for improving protein and milk production of dairy herds |
| US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
| US7556814B2 (en) * | 2003-10-23 | 2009-07-07 | Karp Nelson M | Immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) devoid of CD55 and CD59 in the viral membrane |
| US20050214316A1 (en) | 2003-11-13 | 2005-09-29 | Brown Thomas P | Methods of characterizing infectious bursal disease virus |
| EP1718770B1 (en) | 2004-02-19 | 2011-05-25 | The Governors of the University of Alberta | Leptin promoter polymorphisms and uses thereof |
| RU2283497C1 (ru) * | 2005-04-07 | 2006-09-10 | Общество с ограниченной ответственностью Научно-производственное объединение "Диагностические системы" (ООО НПО "Диагностические системы") | ИММУНОФЕРМЕНТНАЯ ТЕСТ-СИСТЕМА ДЛЯ ИДЕНТИФИКАЦИИ СПЕКТРА АНТИТЕЛ К ВИЧ 1 И 2 ВЫЯВЛЕНИЯ АНТИГЕНА ВИЧ 1 (p24) "ДС-ИФА-АНТИ-ВИЧ 1 И 2, ВИЧ 1 ГРУППЫ О-СПЕКТР+АГ p24 ВИЧ 1" |
| RS51324B (sr) | 2005-04-25 | 2010-12-31 | Merial Ltd. | Vakcine protiv nipah virusa |
| US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
| US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
| CA2629522A1 (en) | 2005-11-14 | 2007-05-18 | Merial Limited | Gene therapy for renal failure |
| US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
| GB2440528A (en) * | 2006-07-27 | 2008-02-06 | Ist Superiore Sanita | Antigen-antibody complexes |
| US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| US8557533B2 (en) * | 2007-02-01 | 2013-10-15 | Helmut Jonuleit | Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4 |
| EP2241626B1 (en) * | 2008-01-09 | 2016-01-06 | Konkuk University Industrial Cooperation Corp | Baculovirus-based vaccines |
| US8603808B2 (en) | 2008-05-08 | 2013-12-10 | Merial Limited | Leishmania vaccine using sand fly salivary immunogen |
| CN103585643A (zh) | 2009-04-03 | 2014-02-19 | 梅里亚有限公司 | 运载新城疫病毒的禽疫苗 |
| TWI627281B (zh) | 2009-09-02 | 2018-06-21 | 百靈佳殷格翰家畜藥品公司 | 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物 |
| WO2011119920A2 (en) | 2010-03-25 | 2011-09-29 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
| WO2012030720A1 (en) | 2010-08-31 | 2012-03-08 | Merial Limited | Newcastle disease virus vectored herpesvirus vaccines |
| AR083533A1 (es) | 2010-10-22 | 2013-03-06 | Boehringer Ingelheim Vetmed | Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe |
| WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
| AU2012240246A1 (en) | 2011-04-04 | 2013-05-09 | Netherlands Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors |
| US20140296248A1 (en) | 2011-04-04 | 2014-10-02 | Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis | Methods and compositions for predicting resistance to anticancer treatment |
| WO2012145577A1 (en) | 2011-04-20 | 2012-10-26 | Merial Limited | Adjuvanted rabies vaccine with improved viscosity profile |
| AP2013007180A0 (en) | 2011-04-25 | 2013-10-31 | Advanced Bioscience Lab Inc | Truncated HIV envelope proteins (ENV), methods andcompositions related thereto |
| EP2714077B1 (en) | 2011-06-01 | 2018-02-28 | Merial, Inc. | Needle-free administration of prrsv vaccines |
| SMT201800284T1 (it) | 2011-06-10 | 2018-07-17 | Univ Oregon Health & Science | Glicoproteine cmv e vettori ricombinanti |
| BR112014001287B1 (pt) | 2011-07-20 | 2020-12-08 | Centre National De La Recherche Scientifique | vacina recombinante do vírus da leucemia felina contendo gene otimizado do envelope do vírus da leucemia felina |
| LT2741740T (lt) | 2011-08-12 | 2017-08-10 | Merial, Inc. | Biologinių produktų, ypatingai vakcinų, vakuuminis konservavimas |
| AR088028A1 (es) | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
| WO2013033092A2 (en) | 2011-09-03 | 2013-03-07 | Boehringer Ingelheim Vetmedica Gmbh | Streptococcus suis pilus antigens |
| WO2013093629A2 (en) | 2011-12-20 | 2013-06-27 | Netherlands Cancer Institute | Modular vaccines, methods and compositions related thereto |
| WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
| ES2711878T3 (es) | 2012-03-20 | 2019-05-08 | Merial Inc | Vacuna contra el virus del herpes equino 1 recombinante que contiene glicoproteína C mutada y usos de la misma |
| WO2014127825A1 (en) | 2013-02-21 | 2014-08-28 | Boehringer Ingelheim Vetmedica Gmbh | H5 proteins of h5n1 influenza virus for use as a medicament |
| EP2968514A1 (en) | 2013-03-12 | 2016-01-20 | Merial, Inc. | Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof |
| CN112316129B (zh) | 2014-04-03 | 2025-01-28 | 勃林格殷格翰动物保健美国有限公司 | 猪流行性腹泻病毒疫苗 |
| WO2016073410A1 (en) | 2014-11-03 | 2016-05-12 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
| ES3050936T3 (en) | 2015-06-23 | 2025-12-23 | Boehringer Ingelheim Vetmedica Gmbh | Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof |
| US9920302B2 (en) | 2015-08-31 | 2018-03-20 | Boehringer Ingelheim Vetmedica Gmbh | Pestivirus vaccines for congenital tremors |
| CA2996613A1 (en) | 2015-09-16 | 2017-03-23 | Boehringer Ingelheim Vetmedica, Inc. | Salmonella choleraesuis-salmonella typhimurium vaccines |
| DK3516064T3 (da) | 2016-09-20 | 2025-07-14 | Boehringer Ingelheim Vetmedica Gmbh | Nye promotorer |
| AU2017332677B2 (en) | 2016-09-20 | 2024-01-11 | Boehringer Ingelheim Vetmedica Gmbh | Canine adenovirus vectors |
| CN109715204B (zh) | 2016-09-20 | 2023-08-22 | 勃林格殷格翰动物保健有限公司 | 新的ehv插入位点orf70 |
| AR109538A1 (es) | 2016-09-20 | 2018-12-19 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna contra la gripe porcina |
| EA201991065A1 (ru) | 2016-11-03 | 2019-11-29 | Вакцина против свиного парвовируса | |
| AU2017353380B2 (en) | 2016-11-03 | 2024-08-22 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof |
| EP3573655A2 (en) | 2017-01-30 | 2019-12-04 | Boehringer Ingelheim Animal Health USA Inc. | Porcine coronavirus vaccines |
| EP3651797A1 (en) | 2017-07-12 | 2020-05-20 | Boehringer Ingelheim Animal Health USA Inc. | Senecavirus a immunogenic compositions and methods thereof |
| KR20200057742A (ko) | 2017-09-23 | 2020-05-26 | 베링거잉겔하임베트메디카게엠베하 | 파라믹소바이러스과 발현 시스템 |
| WO2019092027A1 (en) | 2017-11-09 | 2019-05-16 | Boehringer Ingelheim Vetmedica Gmbh | Sapelovirus immunogenic compositions and uses thereof |
| CN111712575B (zh) | 2018-02-23 | 2024-07-19 | 勃林格殷格翰动物保健有限公司 | 表达外源猫副粘病毒基因的重组病毒载体系统及由其制备的疫苗 |
| JP7245260B2 (ja) | 2018-03-19 | 2023-03-23 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | Ｅｈｖ挿入部位ｕｌ４３ |
| AR115002A1 (es) | 2018-03-19 | 2020-11-18 | Boehringer Ingelheim Vetmedica Gmbh | Ehv con ul18 y/o ul8 inactivados |
| KR20260008832A (ko) | 2018-03-26 | 2026-01-16 | 베링거 인겔하임 애니멀 헬스 유에스에이 인크. | 면역원성 조성물의 제조방법 |
| TW202026010A (zh) | 2018-09-20 | 2020-07-16 | 德商百靈佳殷格翰維美迪加股份有限公司 | 抗豬流行性下痢之鼻內載體疫苗 |
| TW202027785A (zh) | 2018-09-20 | 2020-08-01 | 德商百靈佳殷格翰維美迪加股份有限公司 | 經修飾之pedv棘蛋白 |
| US11858962B2 (en) | 2020-02-06 | 2024-01-02 | Boehringer Ingelheim Vetmedica Gmbh | Polypeptides useful for detecting anti-rhabdovirus antibodies |
| JP2023544396A (ja) | 2020-10-05 | 2023-10-23 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | ロタウイルスに対するワクチン接種のために有用な融合タンパク質 |
| WO2022076977A1 (en) | 2020-10-05 | 2022-04-14 | Boehringer Ingelheim Animal Health USA Inc. | Fusion protein comprising circoviridae capsid protein, and chimeric virus-like particles composed thereof |
| WO2023194913A1 (en) | 2022-04-05 | 2023-10-12 | Boehringer Ingelheim Vetmedica Gmbh | Immunogenic composition useful for vaccination against rotavirus |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE78293T1 (de) * | 1983-05-27 | 1992-08-15 | Texas A & M Univ Sys | Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors. |
| GR862412B (en) * | 1985-09-25 | 1987-01-23 | Oncogen | Vaccines and immuinoassays for acquired immune deficiency syndrome |
| ZA867281B (en) * | 1985-09-25 | 1987-05-27 | Oncogen | Vaccines and immunoassays for acquired immune deficiency syndrome |
| EP0228036A3 (en) * | 1985-12-18 | 1988-09-07 | Microgenesys, Inc. | Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom |
| JPS63258575A (ja) * | 1986-12-15 | 1988-10-26 | レプリゲン コーポレーション | 昆虫細胞中でつくられる組換えｈｉｖエンベロープタンパク |
-
1987
- 1987-10-13 IL IL84154A patent/IL84154A0/xx unknown
- 1987-10-13 IE IE872748A patent/IE872748L/xx unknown
- 1987-10-15 ZA ZA877752A patent/ZA877752B/xx unknown
- 1987-10-15 EP EP87115085A patent/EP0265785A3/en not_active Withdrawn
- 1987-10-16 AR AR87308981A patent/AR241940A1/es active
- 1987-10-16 DD DD87329440A patent/DD283935A5/de not_active IP Right Cessation
- 1987-10-16 AU AU79842/87A patent/AU7984287A/en not_active Abandoned
- 1987-10-16 PL PL1987293520A patent/PL161448B1/pl unknown
- 1987-10-16 DD DD30803987A patent/DD269629A5/de not_active IP Right Cessation
- 1987-10-16 FI FI874564A patent/FI874564A7/fi not_active IP Right Cessation
- 1987-10-16 HU HU874666A patent/HUT45095A/hu unknown
- 1987-10-16 PL PL1987268266A patent/PL161165B1/pl unknown
- 1987-10-16 BR BR8705535A patent/BR8705535A/pt unknown
- 1987-10-16 JP JP62262572A patent/JPS63207397A/ja active Pending
- 1987-10-16 DK DK541987A patent/DK541987A/da not_active Application Discontinuation
- 1987-10-16 DD DD87329441A patent/DD284046A5/de not_active IP Right Cessation
- 1987-10-16 CN CN198787107837A patent/CN87107837A/zh active Pending
-
1991
- 1991-11-29 AU AU88324/91A patent/AU8832491A/en not_active Abandoned
-
1993
- 1993-05-14 LV LVP-93-344A patent/LV10654B/xx unknown
-
1994
- 1994-01-24 LT LTIP1792A patent/LTIP1792A/xx unknown
- 1994-01-24 LT LTIP1793A patent/LTIP1793A/xx not_active Application Discontinuation
- 1994-01-24 LT LTIP1794A patent/LTIP1794A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK541987D0 (da) | 1987-10-16 |
| LV10654A (lv) | 1995-04-20 |
| HUT45095A (en) | 1988-05-30 |
| AR241940A1 (es) | 1993-01-29 |
| PL161448B1 (pl) | 1993-06-30 |
| LTIP1792A (en) | 1995-08-25 |
| EP0265785A3 (en) | 1989-11-08 |
| DD284046A5 (de) | 1990-10-31 |
| ZA877752B (en) | 1989-06-28 |
| AU8832491A (en) | 1992-04-30 |
| PL268266A1 (en) | 1988-08-18 |
| JPS63207397A (ja) | 1988-08-26 |
| DD283935A5 (de) | 1990-10-31 |
| DK541987A (da) | 1988-04-17 |
| FI874564A7 (fi) | 1988-04-17 |
| IE872748L (en) | 1988-04-16 |
| BR8705535A (pt) | 1988-05-24 |
| EP0265785A2 (en) | 1988-05-04 |
| LTIP1794A (en) | 1995-08-25 |
| LTIP1793A (en) | 1995-08-25 |
| AU7984287A (en) | 1988-04-21 |
| DD269629A5 (de) | 1989-07-05 |
| PL161165B1 (pl) | 1993-05-31 |
| LV10654B (en) | 1995-10-20 |
| CN87107837A (zh) | 1988-12-21 |
| FI874564A0 (fi) | 1987-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR241940A1 (es) | Metodo para construir un vector de expresion recombinante de virus de polihedrosis nuclear de autographa californica, sintesis y purificiacion. | |
| GB2181435B (en) | Recombinant lav/htlv virus and vaccines | |
| GB2217718B (en) | Recombinant viruses,vaccines containing them and in vitro cell cultures thereof | |
| IL90489A0 (en) | Recombinant coccidiosis vaccines and their preparation | |
| FR2647808B1 (fr) | Poxvirus recombinant et vaccin contre le virus de l'herpes contenant ce poxvirus | |
| IT8347530A0 (it) | Procedimento per la preparazione di vaccini a base di virus con proteine superficiali ricombinanti e prodotto ottenuto | |
| DE3855947D1 (de) | Peptide mit den immunologischen Eigenschaften von HIV-2 | |
| IL80895A (en) | Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it | |
| NZ211880A (en) | Immunogenic, leukemia-associated viral proteins and vaccines | |
| ZA862812B (en) | Antigens related to envelope glycoprotein of the virus of aids,methods of obtaining these antigens and means employed in these methods | |
| GB2264949B (en) | Measles virus recombinant poxvirus vaccine | |
| EP0298633A3 (en) | Synthetic polypeptides | |
| EP0525828A3 (en) | Recombinant polypeptides and their uses, including assay for aids virus | |
| IL85088A (en) | Anti-malarial peptides,their copolymers and vaccines comprising them | |
| GR3003417T3 (en) | Homogeneous recombinant immune interferon fragments and pharmaceutical compositions containing same | |
| ZA89862B (en) | Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1 | |
| DK720588D0 (da) | Forbindelser til anvendelse ved behandling eller forebyggelse af human-immundefektvirus-(hiv)-infektion, og farmaceutiske praeparater indeholdende samme | |
| NZ224393A (en) | Recombinant hiv envelope proteins and uses thereof | |
| GB8728000D0 (en) | Immunologically active polypeptides useful for preparation of antimalarial vaccines and of diagnostic kits | |
| IL88934A0 (en) | Recombinant human interleukin-1alpha polypeptides,their preparation and pharmaceutical compositions containing them | |
| NZ219192A (en) | Peptides related to p97 melanoma-associated peptide, recombinant virus and vaccines | |
| IL81920A (en) | Vaccines comprising an antigen and interferon-ypsilon and their preparation | |
| IL96647A0 (en) | Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides | |
| IL90048A0 (en) | Recombinant gag precursor of hiv,its preparation and its use as aids vaccine | |
| ZA893085B (en) | Human immunodeficiency virus(hiv)env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |